WO2017147130A3 - Direct fed microbial for prevention of shrimp disease - Google Patents

Direct fed microbial for prevention of shrimp disease Download PDF

Info

Publication number
WO2017147130A3
WO2017147130A3 PCT/US2017/018843 US2017018843W WO2017147130A3 WO 2017147130 A3 WO2017147130 A3 WO 2017147130A3 US 2017018843 W US2017018843 W US 2017018843W WO 2017147130 A3 WO2017147130 A3 WO 2017147130A3
Authority
WO
WIPO (PCT)
Prior art keywords
prevention
fed microbial
direct fed
shrimp disease
shrimp
Prior art date
Application number
PCT/US2017/018843
Other languages
French (fr)
Other versions
WO2017147130A2 (en
Inventor
David Drahos
Seth D'IMPERIO
Original Assignee
Novozymes A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes A/S filed Critical Novozymes A/S
Priority to CN201780009209.6A priority Critical patent/CN108603166A/en
Publication of WO2017147130A2 publication Critical patent/WO2017147130A2/en
Publication of WO2017147130A3 publication Critical patent/WO2017147130A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07—Bacillus
    • C12R2001/125—Bacillus subtilis ; Hay bacillus; Grass bacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Marine Sciences & Fisheries (AREA)
  • General Engineering & Computer Science (AREA)
  • Insects & Arthropods (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to Bacillus subtilis strains and their use for treatment of shrimp disease such as Early Mortality Syndrome.
PCT/US2017/018843 2016-02-23 2017-02-22 Direct fed microbial for prevention of shrimp disease WO2017147130A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201780009209.6A CN108603166A (en) 2016-02-23 2017-02-22 Direct-Fed Microbials for prevention of shrimp disease

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662298578P 2016-02-23 2016-02-23
US62/298,578 2016-02-23

Publications (2)

Publication Number Publication Date
WO2017147130A2 WO2017147130A2 (en) 2017-08-31
WO2017147130A3 true WO2017147130A3 (en) 2017-10-19

Family

ID=58231730

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2017/018843 WO2017147130A2 (en) 2016-02-23 2017-02-22 Direct fed microbial for prevention of shrimp disease

Country Status (3)

Country Link
CN (1) CN108603166A (en)
EC (1) ECSP18071568A (en)
WO (1) WO2017147130A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020001687A (en) * 2017-08-23 2020-07-13 Novozymes As Direct fed microbials for improving the general condition and health of fish.
KR20190082122A (en) * 2017-12-29 2019-07-09 씨제이제일제당 (주) A feed composition for the preventing or treating Acute Hepatopancreatic Necrosis Disease or White Spot Syndrome including Bacillus subtilus
WO2019132605A1 (en) * 2017-12-29 2019-07-04 씨제이제일제당 (주) Feed composition containing bacilius subtilus strain as active ingredient for preventing or treating acute hepatopancreatic necrosis disease or white spot syndrome
GB201911925D0 (en) * 2019-08-20 2019-10-02 Sporegen Ltd Formulations for prevention or reduction of c. difficile infections
CN111690558B (en) * 2020-05-31 2022-04-08 青岛玛斯特生物技术有限公司 Bacillus subtilis strain and application thereof in aquaculture
CN112251370B (en) * 2020-09-03 2023-08-04 福建大北农华有水产科技集团有限公司 Composite microecological preparation containing bacillus subtilis and application thereof
CN112602859A (en) * 2020-12-28 2021-04-06 东台市苏泰饲料有限公司 Feed for preventing and controlling hepatopancreas necrosis syndrome of prawns
CN116948890B (en) * 2023-07-13 2024-03-22 江苏三仪生物工程有限公司 Composite microecological microbial agent for inhibiting vibrio aquiculture and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013155468A2 (en) * 2012-04-12 2013-10-17 Dupont Nutrition Biosciences Aps Microbial strains and their use in animals

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013155468A2 (en) * 2012-04-12 2013-10-17 Dupont Nutrition Biosciences Aps Microbial strains and their use in animals

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
D. R. ZEIGLER ET AL: "The Origins of 168, W23, and Other Bacillus subtilis Legacy Strains", JOURNAL OF BACTERIOLOGY, vol. 190, no. 21, 1 November 2008 (2008-11-01), pages 6983 - 6995, XP055188974, ISSN: 0021-9193, DOI: 10.1128/JB.00722-08 *
HADI ZOKAEIFAR ET AL: "Effects of Bacillus subtilis on the growth performance, digestive enzymes, immune gene expression and disease resistance of white shrimp, Litopenaeus vannamei", FISH AND SHELLFISH IMMUNOLOGY, vol. 33, no. 4, 30 March 2012 (2012-03-30), GB, pages 683 - 689, XP055367147, ISSN: 1050-4648, DOI: 10.1016/j.fsi.2012.05.027 *
HONGYU LIU ET AL: "Isolation of a putative probiotic strain S12 and its effect on growth performance, non-specific immunity and disease-resistance of white shrimp, Litopenaeus vannamei", FISH AND SHELLFISH IMMUNOLOGY, vol. 41, no. 2, 1 December 2014 (2014-12-01), GB, pages 300 - 307, XP055367151, ISSN: 1050-4648, DOI: 10.1016/j.fsi.2014.08.028 *
JOSÉ LUIS BALCÁZAR ET AL: "Inhibitory Activity of Probiotic Bacillus subtilis UTM 126 Against Vibrio Species Confers Protection Against Vibriosis in Juvenile Shrimp (Litopenaeus vannamei)", CURRENT MICROBIOLOGY, SPRINGER-VERLAG, NE, vol. 55, no. 5, 7 August 2007 (2007-08-07), pages 409 - 412, XP019561489, ISSN: 1432-0991, DOI: 10.1007/S00284-007-9000-0 *
VASEEHARAN B ET AL: "Control of pathogenic Vibrio spp. by Bacillus subtilis BT23, a possible probiotic treatment for black tiger shrimp Penaeus monodon", LETTERS IN APPLIED MICROBIOLOGY, OXFORD, GB, vol. 36, no. 2, 1 January 2003 (2003-01-01), pages 83 - 87, XP002339037, ISSN: 1472-765X, DOI: 10.1046/J.1472-765X.2003.01255.X *

Also Published As

Publication number Publication date
CN108603166A (en) 2018-09-28
WO2017147130A2 (en) 2017-08-31
ECSP18071568A (en) 2018-10-31

Similar Documents

Publication Publication Date Title
WO2017147130A3 (en) Direct fed microbial for prevention of shrimp disease
CL2018001349A1 (en) Compositions comprising bacterial strains
CL2018001367A1 (en) Compositions comprising bacterial strains
WO2018229236A3 (en) Compositions comprising bacterial strains
PH12019501557A1 (en) Bacillus isolates and uses thereof
CL2017003142A1 (en) Compositions comprising bacterial strains
CL2018001368A1 (en) Compositions comprising bacterial strains
EA201891970A1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
EP4219713A3 (en) Products and compositions
EA201890048A1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
EA201890047A1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
MX2017002954A (en) Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzo xazole.
IL291460A (en) Bacterial strains, their compositions and their use for the treatment of gastrointestinal disorders
WO2015003816A3 (en) Cystobactamides
WO2015109340A3 (en) Vista antagonist and methods of use
IL291445A (en) Bacterial strains, their compositions and their use for the treatment of gastrointestinal disorders
WO2015104658A3 (en) Amorphous solid dispersion of dapagliflozin and process for the preparation of amorphous dapagliflozin
PH12016501988A1 (en) Antibacterial compounds
MX2020006191A (en) Therapeutic bacteriocins.
WO2016040952A3 (en) BENZOIMIDAZOL-1,2-YL AMIDES AS Kv7 CHANNEL ACTIVATORS
MX2018013164A (en) Novel substituted imidazopyridine compounds as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan-2,3-dioxygenase.
MX2018015410A (en) Oxaborole esters and uses thereof.
MY191930A (en) Microbial lysozyme for use in the treatment of irritable bowel syndrome or inflammatory bowel disease
WO2018004224A3 (en) Novel sporichthyaceae microorganism and use thereof
WO2019048930A3 (en) Bacteriophage for modulating inflammatory bowel disease

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17709256

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 17709256

Country of ref document: EP

Kind code of ref document: A2